INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Open-market saleVerified data

Talasaz AmirAli sold GH

Director, Co-Chief Executive Officer · Guardant Health, Inc. · Common Stock

Side
SELL
Value
$1.56M
Shares
15.0K
Price
$104.21
Executed
Dec 8, 2025
Disclosed
Dec 10, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 8 executedDec 10, 2025 disclosed

GH · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
49/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+14 / 25

    $1.6M reported value · 6.9% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+15 / 15

    6 other actors traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GH

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$19K
    116 sh
    		Oct 16, 2026Oct 19, 2026
    traded Oct 16, 2026
    		+3dSEC FORM 4

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Oct 17, 2026Oct 19, 2026
    traded Oct 17, 2026
    		+2dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    250 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    28
    Jonathan L. JacksonDJoint
    GHGuardant Health, Inc.
    Purchase
    		BUY$15K – $50KSep 28, 2026Oct 19, 2026
    traded Sep 28, 2026
    		+21dHOUSE PTR

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    250 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Oct 17, 2026Oct 19, 2026
    traded Oct 17, 2026
    		+2dSEC FORM 4

    Evidence

    13
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    3,324 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,701 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,340 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,668 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    13
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,701 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,340 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    3,324 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Option exercise
    		M—
    1,668 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    15
    CD
    Chudova DaryaChief Technology Officer
    GHGuardant Health, Inc.
    Tax withholding
    		F$755K
    4,320 sh
    		Oct 1, 2026Oct 2, 2026
    traded Oct 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Sep 17, 2026Sep 21, 2026
    traded Sep 17, 2026
    		+4dSEC FORM 4

    Evidence

    5
    HM
    Hidalgo Medina ManuelDirector
    GHGuardant Health, Inc.
    Option exercise
    		M—
    232 sh
    		Sep 17, 2026Sep 21, 2026
    traded Sep 17, 2026
    		+4dSEC FORM 4

    Evidence

    8
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$20K
    116 sh
    		Sep 16, 2026Sep 17, 2026
    traded Sep 16, 2026
    		+1dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    249 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    0
    TM
    Tariq MusaDirector
    GHGuardant Health, Inc.
    Option exercise · 10b5-1 plan
    		M—
    249 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001753159-25-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 8, 2025
    Published
    Dec 10, 2025
    Ingested by INSIDER
    Nov 5, 04:28 UTC
    Last re-read
    Nov 5, 04:28 UTC

    Extracted facts

    Filer
    Talasaz AmirAli
    Role
    Director, Co-Chief Executive Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Guardant Health, Inc.
    Ticker
    GH
    Shares
    15.0K
    Price per share
    $104.21
    Value
    $1,563,125
    Execution date (reported)
    Dec 8, 2025
    Owned after transaction
    203.2K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 15.0K
    • Price: $104.2083

    = $1,563,125

    What this establishes

    Talasaz AmirAli filed this Form 4 reporting a open-market sale of GH on Dec 8, 2025. It became public on Dec 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Co-Chief Executive Officer
    Talasaz AmirAlicik:0001753159
    Issuer
    Guardant Health, Inc.cik:0001576280

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.